Intermittent intravenous sildenafil for pulmonary hypertension management in neonates and infants

American Journal of Health-System Pharmacy

Volumn 70, Issue 5, 2013, Pages 407-413

  Stultz, Jeremy S ^a   Puthoff, Teresa ^b   Backes, Carl ^c   Nahata, Milap C ^a,d  

^a OHIO STATE UNIVERSITY   (United States)

^b Neonatal Intensive Care Unit   (United States)

^c NATIONWIDE CHILDREN S HOSPITAL   (United States)

^d THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; HYPERTENSIVE AGENT; ILOPROST; NITRIC OXIDE; OCTREOTIDE; SILDENAFIL;

ARTICLE; ARTIFICIAL VENTILATION; BLOOD PRESSURE; CASE REPORT; DRUG EFFICACY; ECHOCARDIOGRAPHY; FEMALE; HUMAN; INFANT; INFANT DISEASE; LUNG DYSPLASIA; MALE; NEWBORN; NEWBORN DISEASE; OXYGEN SATURATION; OXYGEN THERAPY; OXYGENATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; TREATMENT DURATION;

EID: 84874028759     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp120364     Document Type: Article

References (18)

1. Turko IV, Ballard SA, Francis SH et al. Inhibition of cyclic GMP-binding cyclic GMP-specific phosphodiesterase (type 5) by sildenafil and related compounds. Mol Pharmacol. 1999; 56:124-30.
2. Shekerdemian LS, Ravn HB, Penny DJ. Intravenous sildenafil lowers pulmonary vascular resistance in a model of neonatal pulmonary hypertension. Am J Respir Crit Care Med. 2002; 165:1098-102.
3. Baquero H, Soliz A, Neira F et al. Oral sildenafil in infants with persistent pulmonary hypertension of the newborn: a pilot randomized blinded study. Pediatrics. 2006; 117:1077-83.
4. Namachivayam P, Theilen U, Butt WW et al. Sildenafil prevents rebound pulmonary hypertension after withdrawal of nitric oxide in children. Am J Respir Crit Care Med. 2006; 174:1042-7.
5. Mikhail N. Efficacy and safety of sildenafil in patients with congestive heart failure. Arch Intern Med. 2004; 164:2067-8.
6. Huddleston AJ, Knoderer CA, Morris JL et al. Sildenafil for the treatment of pulmonary hypertension in pediatric patients. Pediatr Cardiol. 2009; 30:871-82.
7. Barst RJ, Ivy DD, Gaitan G et al. A randomized, double-blind, placebo-controlled, dose-ranging study of oral sildenafil citrate in treatment-naive children with pulmonary arterial hypertension. Circulation. 2012; 125:324-34.
8. Palma G, Giordano R, Russolillo V et al. Sildenafil therapy for pulmonary hypertension before and after pediatric congenital heart surgery. Tex Heart Inst J. 2011; 38:238-42.
9. Food and Drug Administration. FDA drug safety communication: FDA recommends against use of Revatio in children with pulmonary hypertension. www.fda. gov/Drugs/DrugSafety/ucm317123.htm (accessed 2012 Sep 4).
10. Steinhorn RH, Kinsella J P, Pierce C et al. Intravenous sildenafil in the treatment of neonates with persistent pulmonary hypertension. J Pediatr. 2009; 155:841-847.e1.
11. Mukherjee A, Dombi T, Wittke B et al. Population pharmacokinetics of sildenafil in term neonates: evidence of rapid maturation of metabolic clearance in the early postnatal period. Clin Pharmacol Ther. 2009; 85:56-63.
12. Fraisse A, Butrous G, Taylor MB et al. Intravenous sildenafil for postoperative pulmonary hypertension in children with congenital heart disease. Intensive Care Med. 2011; 37:502-9.
13. Al Hadithy AF, de Goede AL, Eckhardt M et al. Stability of sildenafil (Revatio) dilutions in dextrose 5%. Intensive Care Med. 2011; 37:1899.
14. Stocker C, Penny DJ, Brizard CP et al. Intravenous sildenafil and inhaled nitric oxide: a randomised trial in infants after cardiac surgery. Intensive Care Med. 2003; 29:1996-2003.
15. Nichols DJ, Muirhead GJ, Harness JA. Pharmacokinetics of sildenafil after single oral doses in healthy male subjects: absolute bioavailability, food effects and dose proportionality. Br J Clin Pharmacol. 2002; 53(suppl 1):5S-12S.
16. Vachiery JL, Huez S, Gillies H et al. Safety, tolerability and pharmacokinetics of an intravenous bolus of sildenafil in patients with pulmonary arterial hypertension. Br J Clin Pharmacol. 2011; 71:289-92.
17. Lammers AE, Haworth SG, Pierce CM. Intravenous sildenafil as an effective treatment of pulmonary hypertensive crises during acute intestinal malabsorption. Cardiol Young. 2006; 16:84-6.
18. Ivy DD, Doran AK, Smith KJ et al. Short-and long-term effects of inhaled iloprost therapy in children with pulmonary arterial hypertension. J Am Coll Cardiol. 2008; 51:161-9.